Tumour-infiltrating bystander CD8

Animals CD8-Positive T-Lymphocytes / metabolism Carcinoma, Non-Small-Cell Lung / pathology Humans Interferon-gamma / metabolism Interleukin-15 / metabolism Lung Neoplasms / pathology Mice NK Cell Lectin-Like Receptor Subfamily K / metabolism Tumor Microenvironment
lung cancer non-small cell lung cancer

Journal

Thorax
ISSN: 1468-3296
Titre abrégé: Thorax
Pays: England
ID NLM: 0417353

Informations de publication

Date de publication:
08 2022
Historique:
received: 01 02 2021
accepted: 08 11 2021
pubmed: 3 12 2021
medline: 28 7 2022
entrez: 2 12 2021
Statut: ppublish

Résumé

Tumour-unrelated, virus-specific bystander CD8 We studied the characteristics of bystander CD8 We show that bystander CD8 Thus, the study demonstrates that bystander CD8

Sections du résumé

BACKGROUND
Tumour-unrelated, virus-specific bystander CD8
METHODS
We studied the characteristics of bystander CD8
RESULTS
We show that bystander CD8
CONCLUSION
Thus, the study demonstrates that bystander CD8

Identifiants

DOI: 10.1136/thoraxjnl-2021-217001 PMID: 34853159
pubmed: 34853159
pii: thoraxjnl-2021-217001
doi: 10.1136/thoraxjnl-2021-217001
doi:

Substances chimiques

Interleukin-15 0
NK Cell Lectin-Like Receptor Subfamily K 0
Interferon-gamma 82115-62-6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

769-780

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Galam Leem (G)

Division of Gastroenterology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea (the Republic of).

Minwoo Jeon (M)

Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Korea (the Republic of).

Kun Woo Kim (KW)

Department of Thoracic and Cardiovascular Surgery, Gachon University Gil Medical Center, Incheon, Korea (the Republic of).

Seongju Jeong (S)

Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Korea (the Republic of).

Seong Jin Choi (SJ)

Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Korea (the Republic of).

Yong Joon Lee (YJ)

Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Korea (the Republic of).

Eui-Soon Kim (ES)

Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Korea (the Republic of).

Jae-Ik Lee (JI)

Department of Thoracic and Cardiovascular Surgery, Gachon University Gil Medical Center, Incheon, Korea (the Republic of).

Seung Yeon Ha (SY)

Department of Pathology, Gachon University Gil Medical Center, Incheon, Korea (the Republic of).

Su-Hyung Park (SH)

Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Korea (the Republic of).

Hyo Sup Shim (HS)

Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea (the Republic of).

Jin Gu Lee (JG)

Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea (the Republic of) ecshin@kaist.ac.kr csjglee@yuhs.ac shinm.kang@gmail.com.

Shin Myung Kang (SM)

Division of Pulmonology and Allergy, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea (the Republic of) ecshin@kaist.ac.kr csjglee@yuhs.ac shinm.kang@gmail.com.

Eui-Cheol Shin (EC)

Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Korea (the Republic of) ecshin@kaist.ac.kr csjglee@yuhs.ac shinm.kang@gmail.com.
ORCID: 0000-0003-2480-9202

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Tumour-infiltrating bystander CD8
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Lymphocytes T CD8+ › Tumour-infiltrating bystander CD8
questionsmedicales.fr › Maladies de l'appareil respiratoire › Tumeurs de l'appareil respiratoire › Tumeurs du poumon › Tumeurs des bronches › Carcinome bronchogénique › Carcinome pulmonaire non à petites cellules › Tumour-infiltrating bystander CD8
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Tumour-infiltrating bystander CD8
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Lymphokines › Facteurs d'activation des macrophages › Interféron gamma › Tumour-infiltrating bystander CD8
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Interleukines › Interleukine-15 › Tumour-infiltrating bystander CD8
questionsmedicales.fr › Maladies de l'appareil respiratoire › Tumeurs de l'appareil respiratoire › Tumeurs du poumon › Tumour-infiltrating bystander CD8
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Tumour-infiltrating bystander CD8
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs immunologiques › Récepteurs de cellules tueuses naturelles › Récepteurs de cellules NK de type lectine › Sous-famille K des récepteurs de cellules NK de type lectine › Tumour-infiltrating bystander CD8
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Microenvironnement cellulaire › Microenvironnement tumoral › Tumour-infiltrating bystander CD8